Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LP-005 by Tianchen Biopharmaceutical (Suzhou) for Paroxysmal Nocturnal Hemoglobinuria: Likelihood of Approval
LP-005 is under clinical development by Tianchen Biopharmaceutical (Suzhou) and currently in Phase I for Paroxysmal Nocturnal Hemoglobinuria. According to...